Here are three things that could get shares turned around. OK, so perhaps anything is a bit extreme.
Category: Hepatitis
Should Investors Bet on Gilead Sciences Version 3.0?
CEOMark Pruzanski presented late Wednesday at the J.P. Morgan Healthcare Conference. Pruzanski obviously focused on Intercept’s achievements and plans.